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Lessons from the COVID-19 Pandemic on the Role of Socioeconomic Status 
in Health Outcomes 
Leila Karout 
 
Current Characteristics and Outcomes of COVID-19  
The SARS-CoV-2 (COVID-19) pandemic has evoked extreme 
circumstances for many  around the world. As of the time of this writing, the 
World Health Organization has  reported 159,319,384 confirmed cases of 
COVID-19 and 3,311,780 deaths globally. The  United States alone has seen a 
total of 32,424,637 confirmed cases and 576,814 total  deaths.1 While risk factors, 
clinical characteristics of patients, mortality, and morbidity  are all under 
consistent study, the information we have now on the pandemic and its  effects on 
various populations shows similar patterns and themes. Current research has  
shown that severe obesity, hypertension, diabetes, cardiovascular diseases 
(CVDs), and  kidney disease are the most prevalent underlying health conditions 
for individuals with  COVID-19. These conditions have demonstrated an increase 
in morbidity of the virus.2, 3, 4, 5, 6, 7. 8, 9 As of May 18th, 2020, the CDC reported 
8,134 (76.4%) of deaths from COVID 19 to be associated with at least one 
underlying medical condition (including 83.1% of  deaths for those under 65 
years). The most common being cardiovascular disease  (60.9%), diabetes 
mellitus (39.5%), chronic kidney disease (20.8%), and chronic lung  disease 
(19.2%).7  
SES is a complex composition of social and economic factors that 
influence an  individual, or a community’s experiences. Socioeconomic status 
(SES) plays a substantial  role in an individual’s life due to the resources and 
opportunities that come along with it  such as education, quality healthcare access, 
financial stability, social status, and  race/ethnicity as a socioeconomic factor.38 
Individuals from lower SES are at a higher risk  for illness susceptibility and 
severity.12,13 This is especially prevalent during the current  pandemic, where daily 
life has drastically changed, including detrimental social and  financial challenges 
for many. Psychological stress due to restrictions on social behavior,  the ability 
to see loved ones, and having an unstable occupation, has created outcomes  such 
as depression, health anxiety, and financial worry.18 Low SES can aggravate these  
outcomes due to the higher likelihood of risk factors such as pre-existing financial  
instability, lack of healthcare access, and the higher prevalence of pre-existing 
diseases  associated with COVID-19 such as asthma, CVD, hypertension, chronic 
kidney disease  (CKD), diabetes, and obesity.10, 9, 19, 20 Therefore, it is essential to 
examine the role of SES  during the COVID-19 pandemic to be better prepared to 
protect the most at-risk  populations and find room for improvement in the 
                                               
1 See endnotes for references. 
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healthcare system that would support  optimal prevention and treatment of such a 
virus universally.  
 
The Complex Role of SES as a Risk Factor for COVID-19 Severity and 
Susceptibility  
Current trends are highlighting the association between COVID-19 rates 
and SES, as well  as race/ethnicity. New York City is an important example, as it 
experienced the highest rates of infections in the United States.10 The Bronx, a 
borough of New York City, has  disproportionate rates of hospitalization and 
death than any other region within the city. It also ranks last in New York State 
for health outcomes, quality of life, and socioeconomic factors,9 while 
consistently showing the highest rates of hypertension, diabetes, and  asthma, 
exacerbated by their socioeconomic conditions.10 Furthermore, Palaiodimos et al., 
found obesity to be the most significant factor in COVID-19 mortality and 
severity, even after adjusting for other clinical characteristics such as diabetes, 
coronary artery disease, heart failure, COPD, CKD, and smoking. Comparingly, 
about 33% of residents  in the Bronx are obese, more than any other borough in 
New York City. Diabetes and  hypertension are also most prevalent in the Bronx 
compared to other New York  counties.9 These associations are not exclusive to 
New York City. According to the CDC, the age-adjusted hospitalization rates for 
African-American, Alaska Native, and  American Indian populations are 5 times 
that of White people. Hospitalization rates for  Hispanic/Latino ethnicity are 4 
times that of Non-Hispanic White people.39 Black, Asian,  and Minority Ethnic 
(BAME) populations are at increased risk for poor health outcomes  due to 
socioeconomic inequalities such as less access to healthcare, and higher rates of  
disease such as diabetes, hypertension, obesity, and cardiovascular conditions.35,36  
The  association between COVID-19 infection and SES is becoming more 
clear and is consistent with previous pandemics such as the 2009/2010 H1N1 
outbreak.9,11 These  inequalities can be contributed to differences in living 
conditions, occupation, and  systemic challenges.9 Pre-existing inequalities have 
been reinforced by the COVID-19 pandemic. For example, the CDC reported that 
33% of COVID infections were  represented by Black Americans in a study of 99 
counties, despite making up 18% of the  population. Black counties also 
experience six times the death rate compared to the  majority of White counties.25 
Similarly in Chicago, African American residents represented 72 percent of 
COVID-19 deaths, while making up only 29 percent of Chicago's population in 
April of 2020.28 Golestaneh et al., also found Black Americans to be more likely 
to test positive and be hospitalized due to COVID-19 even when clinical and 
sociodemographic factors were adjusted.25 Such differences can be related to 
several  factors, such as minority populations having higher rates of 
comorbidities, lower SES  (thus lower chance of access to care), and the fact that 
130 
the majority of front-line workers are of minority and low SES backgrounds.27 
Financial distress and poor health care  access are linked to adverse health 
outcomes and heavier disease burden over the course  of life. This is significant as 
we know that older populations are at particularly higher risk  for COVID-19 and 
experience worse morbidity and mortality.26 Income inequality within  society has 
damaging effects on the physical and social well-being of populations.13 In a  
longitudinal analysis by Robinette et al., the chance of developing and/or having 
more  than two chronic health conditions decreased for every 10,000 dollar 
increment in  neighborhood income.12  
The Distressed Communities Index (DCI) can be a useful tool to 
quantitatively examine the relationships between SES and health outcomes such 
as with COVID-19. The DCI accounts for seven socioeconomic factors such as 
unemployment, education, poverty rate, median income, business growth, and 
housing vacancies. A  higher county DCI score was associated with more 
COVID-19 deaths per 100,000 people  than non-distressed counties. While this 
can be explained by the higher prevalence of  comorbidities and age, the 
association between COVID-19 mortality and socioeconomic status was stronger 
than that with underlying medical conditions.29  
Pre-existing medical  conditions are well known to put an individual at a 
much higher risk for poor COVID-19 outcomes. However, pre-existing medical 
conditions on their own do not represent the  most accurate estimation for 
infection severity and susceptibility. Exposure to the virus  and access to optimal 
treatment and preventative care is very significant when examining  vulnerability 
to COVID-19 and predicting the severity of prognosis. The work of Wiemer et al. 
uses a predictive model to examine the vulnerability to “in-patient hospitalization 
for respiratory conditions for the U.S. and how vulnerability varies by education, 
income,  and race-ethnicity” using an index of relative vulnerability (VI).2 
Substantial differences in vulnerability are found due to inequalities across race 
and socioeconomic status particularly in terms of pre-existing health conditions. 
Notably, these disparities are  present earlier in life, before age 65. Non-Hispanic 
(NH) Blacks were found to have more risk factors on average than Non-Hispanic 
Whites, including a higher prevalence of  hypertension but had lower VI among 
all ages. Vulnerability was found to be 60% higher for those with an education of 
high school or less than with a college degree, and VI was higher for those in the 
lower quartile of household income across all age groups. Among those who are 
25 years or older, a 3-fold difference was found between individuals in the lowest 
quartile of household income than those in the top quartile. Wiemer makes the  
important distinction between exposure and susceptibility to infection. While no  
difference was found in vulnerability index (VI) between NH Blacks and NH 
Whites, when examined within age groups (specifically 45-64, 65+) NH Blacks 
had higher VI. This points to significant differences in exposure that can be 
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related to varying health conditions among the two populations. Likewise, 
Hispanics were found to have lower VI  than NH Whites and NH Blacks despite 
high hospitalization rates, suggesting significant  exposure rates.2  
 
Linking SES and Poor Health Outcomes from a Biological Perspective  
Low socioeconomic status can be a source of psychological stress for 
individuals and  families due to financial and social burdens. When the stressors 
associated with low SES are experienced early in life, and/or consistently 
throughout life, overall health is at risk. Thus, during a pandemic of a highly 
contagious virus such as COVID-19, SES becomes a risk factor for increased 
severity of infection. A growing body of evidence is continuing to reveal the 
biological link between low SES and adverse effects such as cellular  
senescence.14, 15, 17 Cellular senescence refers to the cessation of cell division. 
Chronic  cellular senescence can occur in response to long-term stress and 
negatively impacts the  immune system.17,42 A study by Elwenspoek et al., found 
that in a group of healthy participants, early life adversity (ELA), promoted 
cytomegalovirus (CMV), an important driving force of immunosenescence--the 
progressive decline of the immune system.17 Low SES was also shown by Dowd 
& Aiello to be associated with an impaired immune response to CMV. This 
further suggests that low SES is a risk factor for worse health outcomes and 
poorer immune response to infection.37  
The relationship between immune dysfunction, ELA, and SES is critical 
towards understanding the role SES has on the  severity and susceptibility of 
COVID-19. Data has shown that a dysfunctional immune cell response and 
abundance of senescent cells, will negatively impact the prognosis of  COVID-19. 
Senescent immune cells produce pro-inflammatory cells16 and show elevated  
levels of cytotoxicity.17 Accelerated and chronic immunosenescence of cells 
would lead  to a higher likelihood of mortality and morbidity of disease.21 Severe 
COVID-19 patients  have more non-functional, and senescent immune cells, as 
well as increased cytokine  release storm which is an inflammatory response by 
immune cells to endogenous/exogenous stress. Thus, COVID-19 can mimic 
immunosenescence, as  outlined by Omarjee et al.24 Proper immune function is 
necessary for the least severe COVID-19 outcome.16 The association between an 
altered immune response to infection and SES highlights one way in which low 
SES individuals are especially vulnerable to COVID-19 severity and 
susceptibility. It is important to address the challenges associated  with low SES, 
to ensure proper prevention and treatment of COVID-19 and other  infectious 
diseases. Prevention strategies can include mental health screenings, counseling 
services, and access to primary care for low SES communities.  
 
Improving Access to Care and Rethinking the Healthcare System for Health 
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Equity  
It has become clear that significant discrepancies exist within different 
populations of  society. Data has pointed to disproportionate COVID-19 infection 
rates, illness severity,  susceptibility, and morbidity. To address these issues, 
access to care must be held as a priority. Challenges within the healthcare system 
should be improved and acknowledged.  Even before the COVID-19 pandemic, 
socioeconomic inequalities have been a barrier to receiving healthcare, especially 
primary care facilities that include not only treatment but  preventative services. 
The U.S. has struggled to provide affordable access to care even before the 
pandemic, and now these issues are becoming more prevalent. In 2018,  
approximately 8.5% of the population (27.5 million people) were uninsured. This 
is important as the majority of the population receives insurance through their 
employer, employer-sponsored insurance (ESI). During an economic crisis 
exasperated by a  pandemic, job loss is high and thus health insurance is low 
when it is needed most. As of  April of 2020, the unemployment rate hit 14.7%, 
the lowest since World War II.30 And, if  employment is not lost, health insurance 
coverage could still be at risk due to employers cutting costs. On the other hand, a 
public insurance system could unlink employment and insurance, improving some 
of the downfalls of private insurance.31 The quality of health coverage is 
influenced by the premium paid per month, meaning quality care decreases with 
lower income. This can also influence whether an individual seeks care due to 
extra costs from copays, even with ESI.34 Likewise, in a poll regarding seeking 
care during  COVID-19, 68% of Americans state they would delay or avoid 
seeking care if they  suspected having symptoms of the virus due to cost.33 Similar 
reluctances to seek care was observed in another survey further emphasizing the 
association between SES and unwillingness to seek care for financial reasons 
during COVID-19.41 Measures such as the Families First Coronavirus Response 
Act requires insurers such as Medicare, Medicare Advantage, and Medicaid to 
eliminate copayments, deductibles and coinsurance payments for COVID-19 
testing services. However, this does not take into account services for treatment 
and hospitalization. The same is seen with the Coronavirus Aide, Relief and 
Economic Security Act (CARES), where costs associated with treatment  are not 
addressed.33 Blumenthal et al. highlights the flaws within ESI including the lack  
of implementation of laws such as the Affordable Care Act (ACA) due to lack of  
education about eligibilities, and that 14 states have opted out of the ACA.31  
Smith and Fraser32 outline important strategies for improving systemic 
challenges such as improving and expanding data and analytic capabilities, 
expanding public health  laboratory capacities, and increasing the number of CDC 
public health advisors who work with staff in ministries of health and 
governmental public health. Furthermore, it is notable that “the budget for the 
CDC’s Public Health Emergency Preparedness cooperative agreement has been 
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reduced by almost one third” from federal fiscal year (FFY) 2002 to FFY2019 
despite congress having invested in federal, state, and local public health 
preparedness programs after events of September 11 and the anthrax  attack.32 
Quality data and analytics are also necessary for adequate disease surveillance  
and to make timely, informed decisions. This is significant for reducing 
inequalities  within SES by providing data on different communities and 
ultimately using this to  develop prevention and response strategies that will 
therefore address the most vulnerable  populations, and thus decrease infection 
overall. Addressing SES challenges is also  essential for disease surveillance as 
universal access to care would ensure significantly more individuals being 
tested.23 Such strategies can drastically improve the preparedness capabilities of 
the public health system. The U.S. had 17.7% of the nation’s gross domestic 
product (GDP) spent on healthcare in 2018, compared to the Organization for  
Economic Cooperation and Development (OECD) average of 8.8%, with disease 
burden  being 28% compared to the OECD average of 17.5%. These diseases 
include those that put Americans at higher risk of COVID-19: hypertension, heart 
disease, diabetes, chronic  lung disease.34 
 
Lessons from the Pandemic  
While the U.S. population constitutes 6% of the world’s population, the 
U.S. represents  26% of COVID-19 cases and 24% of COVID-19 deaths.31 This 
alone is cause for more  focus on research and implementation of strategies to 
address issues within the healthcare  system. The relationship between SES and 
the health outcomes during the COVID-19 pandemic serves as a lesson to be 
learned from. The inequalities we see among different SES populations and race-
ethnicity can be attributed to a substantial wealth gap, systemic  inequalities, and 
a flawed healthcare system. Specifically, the COVID-19 pandemic has  also 
emphasized the crucial need for affordable healthcare that is accessible to all,  
regardless of SES. This is necessary for the health of the country, as well as 
crucial to properly address public health emergencies such as COVID-19. It is 
also important to note that the outcomes of the current pandemic have been 
experienced before, such as  during the 2009 H1N1 influenza pandemic, where 
vulnerable populations experienced the worst outcomes due to poor healthcare 
access and increase susceptibility and exposure to the virus.40 By acknowledging 
the populations most at risk, the cause of said  risk, and addressing preparedness 
capacities and strategies outlined above by Smith and  Fraser,32 we may be much 
better prepared to optimally control public health emergencies.  Furthermore, it is 
important to implement strategies for increasing data collection of race  and 
ethnicity such as the Equitable Data Collection and Disclosure on COVID‐19 Act,  
which aims to establish a standardized repository for race/ethnicity data related to  
COVID‐19.28 Research on the relationship between SES and increased prevalence 
134 
on disease burden is also important as the link has been extensively studied, but 
the root cause of this association is not as well known. A public health approach 
that recognizes the social, environmental, economic, and personal impact of 
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